Pyoderma gangrenosum and leg ulcers associated with vasculitis: importance of addressing the underlying disease process when treating inflammatory wounds.
Burch
Jennie
J
St Mark's Hospital, Harrow, Middlesex HA1 3UJ, UK. jennie.burch@nwlh.nhs.uk
Jones
Margaret
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D047070:Bandages, Hydrocolloid; D015984:Causality; D003125:Colostomy / Q000009:adverse effects; D004322:Drainage / Q000379:methods / Q000451:nursing; D004338:Drug Combinations; D005260:Female; D005780:Gelatin / Q000627:therapeutic use; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007871:Leg Ulcer / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009720:Nurse Clinicians; D009730:Nursing Assessment; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010347:Patient Care Planning; D017511:Pyoderma Gangrenosum / Q000209:etiology / Q000517:prevention & control; D012017:Referral and Consultation; D017592:Skin Care / Q000379:methods / Q000451:nursing; D016559:Tacrolimus / Q000627:therapeutic use; D014657:Vasculitis / Q000150:complications / Q000517:prevention & control; D014945:Wound Healing / Q000276:immunology; D017967:Zinc Compounds / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D017967:Zinc Compounds; C009622:gelatin, glycerin, zinc oxide drug combination; D005780:Gelatin; D005990:Glycerol; D016559:Tacrolimus